跳至主要内容
临床试验/NCT00397267
NCT00397267Unknown4 期

Treatment of Acute Asthma in ER With Combination of Systemic Steroids and Inhaled Steroids

Soroka University Medical Center2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2007年1月最近更新:
适应症
相关药物

试验速览

阶段
4 期
入组人数
120
试验地点
2
主要终点
PFT improvment

研究概览

简要总结

We assume that the combination of systemic steroids and inhaled steroid in the first hour of treatment in the ER will decrease the admission rate and improve faster the pulmonary function.

120 patients refferd to the ER due to asthma attack aged 18-60 with PFR < 60% 0o predicted will participate in the study after giving informed consent.

The usual treatment in the ER is inhalation of Beta 2 short acting and I.V solumedrol 120 mg . The study group will recieve in addition 3 inhalation of Budesonide 1000 microgram each during the first hour.

The controlled group will recieve Nacl 0.9% PFR will be followed 0 30 60 120 min.

详细描述

Primary end points- PFT improvment and admission rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Asthmatic patients aged 18-60 with PFR < 60% of predicted

排除标准

  • Patients with other chronic diseases
  • cardiac renal hepatic etc will be excluded

结局指标

主要结局

PFT improvment

Admission rate

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验